Physician profile
Loubert S Suddaby
NPI 1609869783
$322,973.25
in general payments reported to CMS, 2019-2025
19 companies · $20K in 2025
The $20K reported for 2025 was more than what 90% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69K · 2020: $56K · 2021: $74K · 2022: $44K · 2023: $36K · 2024: $23K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $77K · Food and Beverage: $1,645 · Travel and Lodging: $1,288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $76,628.25 |
| Food and Beverage | $1,645.25 |
| Travel and Lodging | $1,287.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $275,514.93 | 2019-2025 | Sahara Stabilization System |
| Vb Spine LLC | $13,416.07 | 2025 | Sahara Stabilization System |
| Kyocera Medical Technologies, INC. | $12,400.00 | 2021 | |
| Abbott Laboratories | $8,433.26 | 2019-2024 | Penta, Proclaim, Eterna |
| Globus Medical, INC. | $7,294.42 | 2019-2022 | |
| Bacterin International INC | $3,275.00 | 2019 | |
| Arthrex, INC. | $1,095.90 | 2025 | |
| Prodigy Surgical Distribution, INC. | $514.85 | 2025 | |
| Integra Lifesciences Corporation | $291.25 | 2019-2020 | |
| Medtronic USA, INC. | $196.31 | 2019 | |
| Orthofix Medical, INC. | $144.02 | 2021 | |
| Arbor Pharmaceuticals, INC. | $119.15 | 2020-2022 | |
| Assertio Therapeutics, INC. | $107.06 | 2019-2020 | |
| Nevro Corp. | $73.94 | 2019-2020 | |
| Zyla Life Sciences, INC. | $37.34 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $17.68 | 2019 | |
| Arteriocyte Medical Systems, INC. | $16.58 | 2023 | Magellan |
| Brainlab, INC. | $13.21 | 2022 | |
| Horizon Therapeutics Plc | $12.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loubert Suddaby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.